All In MedTech

FDA Clearance Tracker · P990004

SURGIFOAM ABSORBABLE GELATIN SPONGE, USP

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Sep 30, 1999 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Sep 30, 1999

Approved

Time to decision

251 days

Received Jan 22, 1999. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P990004
Device name
SURGIFOAM ABSORBABLE GELATIN SPONGE, USP
Applicant location
Soeborg
Received
Jan 22, 1999
Decided
Sep 30, 1999
Decision
Approved
Supplements
79 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Regulation
21 CFR 878.4490

Every decision under product code LMF

FDA's approval statement

As written in FDA's record.

Approval for the SURGIFOAM Absorbable Gelatin Sponge, U.S.P. This device is indicated for surgical procedures (except urologic, ophthalmic and neurologic) for hemostasis, when control of capillary, venous and arteriolar bleeding by pressure, ligature and other conventional procedures is ineffective or impractical.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code LMF. The earliest in FDA's data is N17600, decided Aug 26, 1976.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Ferrosan Meidcal Devices A/S

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.